CrushSCI.com
116.1平均天数
125中位天数
62最短天数
171最长天数
842025发文量

Paper Review Records

全部论文审稿周期

11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

107 天

Double heterozygous pathogenic germline APC and MSH2 variants in a 16-year-old female diagnosed with colorectal cancer

作者
Elena Maccaroni; Riccardo Bacalini; Alessia Lancianese; Cecilia Copparoni; Riccardo Giampieri; Francesca Bianchi; C. Brugiati; Laura Belvederesi; Elisa Ambrosini; Natalia Chiodi; Emma Nicol Serritelli; Giulia Ricci; Valentina Tarantino; Manuela Santarosa; Francesca Morgese; Alice Magnarini; Silvia Villani; Veronica Agostinelli; Giulia Mentrasti; Alessandra Mandolesi; Gaia Goteri; Paola Coccia; Rossana Berardi展开收起
作者单位
1. Azienda Ospedaliero-Universitaria delle Marche; 2. Marche Polytechnic University; 3. Oncology Unit, "Santa Maria Della Misericordia" Hospital, 61029, Urbino, Italy; 4. Centro di Riferimento Oncologico展开收起
PDF源文件 DOI 网页
125 天

Optimizing MRI sequences and apparent diffusion coefficient parameters for small pancreatic ductal adenocarcinoma detection

作者
Naoko Mori展开收起
作者单位
1. Department of Radiology, Akita University Graduate School of Medicine, Akita, Japan展开收起
PDF源文件 DOI 网页
156 天

Addressing uncertainty in hereditary colorectal cancer: the role of a regional expert multidisciplinary team meeting

作者
Avani Varde; Terri McVeigh; Vicky Cuthill; Angela F. Brady; Bianca DeSouza; Andrew Latchford; Kevin J. Monahan展开收起
作者单位
1. The Centre for Familial Intestinal Cancer, St Mark’s The National Bowel Hospital, London, UK; 2. Surgery and Cancer, Imperial College, London, UK; 3. The Royal Marsden Hospital, London, UK; 4. North West Thames Regional Genetics Service, London, UK展开收起
PDF源文件 DOI 网页
157 天

Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study

作者
Serene Ong; Zi Yang Chua; Jeanette Yuen; Jianbang Chiang; Zhang Zewen; Joanne Ngeow; Tamra Lysaght展开收起
作者单位
1. Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 2. Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore; 3. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; 4. Sydney Health Ethics, University of Sydney, Sydney, Australia展开收起
PDF源文件 DOI 网页
171 天

A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer

作者
Fernández Mercè; Queralt Asla; Francisco J. Illana; Fusté Victòria; Hernández-Losa Javier; Sesé Marta; Carmela Iglesias; Susan M. Webb; Anna Aulinas展开收起
作者单位
1. Department of Endocrinology and Nutrition, Institut de Recerca Sant Pau (IR SANTPAU), Endo-ERN. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 2. Department of Endocrinology and Nutrition, Centre d’Atenció Integral Dos de Maig, Consorci Sanitari Integral, Barcelona, Spain; 3. Faculty of Medicine, University of Vic-Central University of Catalonia, Vic, Spain; 4. Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona, Spain; 5. Department of Pathological Anatomy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 6. Department of Pathological Anatomy, Vall d’Hebrón Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain; 7. Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; 8. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Instituto de Salud Carlos III (ISCIII), Madrid, Spain展开收起
PDF源文件 DOI 网页
143 天

CHEK2 -related breast cancer: real-world challenges

作者
Luiza N. Weis; Brittany L. Bychkovsky; Adela Rodríguez Hernandez; Romualdo Barroso-Sousa; Renata L. Sandoval展开收起
作者单位
1. Dasa Oncology, Hospital Brasília, Brasília, Brazil; 2. Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, USA; 3. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 4. Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; 5. Harvard Medical School, Boston, USA; 6. Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; 7. Department of Medicine, University of Barcelona, Barcelona, Spain; 8. Hospital Sírio-Libanês, Brasília, Brazil展开收起
PDF源文件 DOI 网页

FAQ

Familial Cancer审稿要多久?

截至2026-11-19,CrushSCI 收录了 Familial Cancer 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 62 天(New RPS20 gene variant in colorectal cancer diagnosis: insight from a large series of patients,2024-11-28 收稿,2025-01-29 录用),最慢一篇用了 171 天;平均 116.1 天,中位数 125 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。